Blood markers for benign vs. malignant pancreas changes
Part of Cancer, Digestive system clinical trials.
This study looks for markers in the body that can tell the difference between harmless (benign) and dangerous (malignant) pancreatic growths. It may help doctors learn more about changes in the pancreas and guide better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a non-cancerous (benign) pancreatic condition, like chronic or acute pancreatitis.
- If you had acute pancreatitis, it must have been more than 4 weeks ago.
- Your doctor has recommended an echo-endoscopy (a special scope test) to look for signs of early pancreatic changes.
- You do not have pancreatic cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tumor “markers” (tests on cancer tissue or related information) to understand how you may respond to first-line treatment for pancreatic cancer. Your results may help doctors better predict which treatments work best for different people.
This study looks for proteins in the blood that could help doctors tell the difference between pancreatic cancer and non-cancerous pancreatic conditions, such as chronic pancreatitis or benign cysts. By participating, you could help improve early and accurate diagnosis, which may lead to better outcomes for future patients.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This study looks at “biomarkers” (test signals in tissue or blood) in people with pancreatic cancer. It may help researchers understand the disease better and find ways to predict or track it.
This study looks for new markers in the blood or tissue of people with a pancreatic mass that might be cancer. It uses samples from a routine biopsy or surgery to help doctors learn more about the disease.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
Hear when a new Benign Pancreatic Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.